Li Kang Biomedical Co Ltd
Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded i… Read more
Li Kang Biomedical Co Ltd - Asset Resilience Ratio
Li Kang Biomedical Co Ltd (6242) has an Asset Resilience Ratio of 12.21% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Li Kang Biomedical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Li Kang Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$141.28 Million | 12.21% |
| Total Liquid Assets | NT$141.28 Million | 12.21% |
Asset Resilience Insights
- Moderate Liquidity: Li Kang Biomedical Co Ltd has 12.21% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Li Kang Biomedical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Li Kang Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Guangzhou Dongfang Hotel Co Ltd
SHE:000524 |
Travel Services | 0.01% |
|
Hna-Caissa Travel Group Co Ltd
SHE:000796 |
Travel Services | 0.00% |
|
Emei Shan Tourism Co Ltd
SHE:000888 |
Travel Services | 0.01% |
|
Wuhan Sante Cableway Group Co Ltd
SHE:002159 |
Travel Services | -4.67% |
|
Parlo Bhd
KLSE:0022 |
Travel Services | 27.97% |
|
Beijing Utour International Travel Service Co Ltd
SHE:002707 |
Travel Services | 0.83% |
|
Hana Tour
KO:039130 |
Travel Services | 26.56% |
|
Sejoong Co. Ltd
KQ:039310 |
Travel Services | 29.81% |
Annual Asset Resilience Ratio for Li Kang Biomedical Co Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Li Kang Biomedical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 37.61% | NT$389.45 Million | NT$1.04 Billion | +14.73pp |
| 2023-12-31 | 22.88% | NT$189.18 Million | NT$827.00 Million | +3.80pp |
| 2022-12-31 | 19.08% | NT$131.42 Million | NT$688.84 Million | +7.00pp |
| 2021-12-31 | 12.08% | NT$74.39 Million | NT$616.07 Million | -6.92pp |
| 2020-12-31 | 19.00% | NT$122.50 Million | NT$644.77 Million | +10.72pp |
| 2019-12-31 | 8.28% | NT$51.84 Million | NT$626.44 Million | +3.71pp |
| 2013-12-31 | 4.56% | NT$5.10 Million | NT$111.79 Million | +2.13pp |
| 2009-12-31 | 2.43% | NT$6.15 Million | NT$252.83 Million | -1.75pp |
| 2008-12-31 | 4.18% | NT$18.34 Million | NT$438.89 Million | +2.75pp |
| 2007-12-31 | 1.43% | NT$10.01 Million | NT$701.86 Million | -0.50pp |
| 2006-12-31 | 1.92% | NT$14.56 Million | NT$757.63 Million | -0.42pp |
| 2005-12-31 | 2.34% | NT$18.54 Million | NT$791.11 Million | -0.01pp |
| 2004-12-31 | 2.35% | NT$18.05 Million | NT$766.35 Million | -0.48pp |
| 2003-12-31 | 2.83% | NT$21.82 Million | NT$770.15 Million | +1.37pp |
| 2002-12-31 | 1.47% | NT$11.24 Million | NT$765.96 Million | -- |